Early Access — free while we kick the tires
EdgarHawk

NATIONAL HEALTH CORP

2 filings analyzed · 1 company · Latest 2025-01-03

Companies

Company Buys Sells Direction
NATIONAL HEALTHCARE CORP NHC 0 2 Net selling

Activity

January 2025
medium
Sell
25,729 shares
$2,774,857
Significance 4/10

Insider at National Healthcare Corp (NHC) sold 25,729 shares for $2,774,857.21 on 2024-12-31; stock down -22.1% from 52-week high

An insider at National Healthcare Corp sold 25,729 shares at $107.85 on 2024-12-31, reducing holdings by 2.4% to 1,030,887 shares. The stock has declined -22.1% from its 52-week high of $137.13 and is currently trading at $106.80, down -15.9% over the past 30 days. Fundamentals remain solid with P/E of 13.27, annual revenue growth of 5.1%, and net income of $42,789,000.00, suggesting the decline is driven by sentiment rather than deterioration in operations. The insider's cross-ticker track record shows only 1 prior sell, and same-ticker history shows a recent sale on 2024-12-20, though outcome measurement is not yet available for either trade.

December 2024
medium
Sell
28,147 shares
$3,200,545
Significance 5/10

National Health Corp sells 28,147 shares of NHC at $113.71; holds 1,056,616 shares post-sale amid 18.5% decline from 52-week high.

An insider at National Health Corp sold 28,147 shares for $3.2M, reducing holdings by 2.6% to 1,056,616 shares remaining. The sale occurred at $113.71, while the stock currently trades at $111.76—a 1.7% decline from the transaction price—and stands 18.5% below its 52-week high of $137.13. The company's fundamentals remain solid with quarterly revenue of $340.2M, net income of $42.8M, and a P/E of 13.88, though the stock has declined 11.4% over the past 30 days and 9.9% over 90 days. The transaction represents a moderate reduction in a substantial insider position but does not constitute a complete exit; the lack of a broader selling pattern or disclosed motivation limits the signal clarity for investors interpreting this single transaction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access